Guardian Pharmacy Services, Inc. (GRDN) Reports Q2 EPS of $0.29 ; Offers Guidance

Guardian Pharmacy Services, Inc. (NYSE: GRDN) reported Q2 EPS of $0.29. Revenue for the quarter came in at $351.77 million.

FY 2026 Outlook:-
Revenue between $1.4434 billion to $1.45 billion vs consensus $1.42 billion.

For earnings history and earnings-related data on Guardian Pharmacy Services, Inc. (GRDN) click here.

You May Also Be Interested In

• Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
• Rockwell Medical (RMTI) Misses Q2 EPS by 1c
• Citi raises Cooper Companies price target to $80, keeps Neutral